Mortality is approximately 5% among all patients with acute pancreatitis and has been as high as 20 to 30% among those with severe cases, 3, 4 although this rate may be declining. 5 Patients with progressive multisystem organ dysfunction are at highest risk for death, and in one study, mortality among such patients was reported to be higher than 50%. 6 Deaths that occur within the first 2 weeks after the pancreatitis episode are usually due to the systemic inflammatory response syndrome and multisystem organ failure, 6 whereas deaths that occur later are typically attributable to complications of necrotizing pancreatitis.
PATHOPH YSIOL OGY A ND EFFEC T S OF THER A PY
The pathogenesis of gallstone pancreatitis remains unclear. Studies have suggested that a gallstone may compress the septum between the distal biliary and pancreatic ducts, resulting in obstruction of the pancreatic duct, or it may settle in the common channel (the ampulla of Vater), resulting in reflux of bile into the pancreatic duct (Fig. 1A ). Both mechanisms may lead to increased pressure in the pancreatic duct. The sequelae of pancreatic-duct obstruction (reflux of pancreatic and biliary secretions, pancreatic-duct hypertension, and aberrant secretion of acinar cells) result in pancreatic-duct injury, with the release of pancreatic enzymes into the glandular interstitium causing pancreatic autodigestion and triggering acute pancreatitis. [7] [8] [9] [10] It appears that the acute onset of ductal obstruction is important, since not all patients with chronic pancreatitis and an obstructed pancreatic duct (and few patients with pancreatic cancer) present with an acute episode of pancreatitis. It is unclear why most cases of biliary pancreatitis resolve uneventfully, whereas some progress rapidly to the more severe form. A study of experimentally induced pancreatic-duct obstruction in opossums has shown that necrosis is more severe in animals with coexisting pancreatobiliary reflux. 11 If a long common channel, which is present in a small percentage of humans, is necessary for bile reflux to occur, this may explain why severe pancreatitis develops in only a minority of patients with bile-duct stones. 12 However, in opossums pancre atitis from pancreatic-duct obstruction may develop even if biliary reflux is prevented surgically. 11 Furthermore, in dogs, perfusion of the pancreas with bile under physiologic conditions does not lead to pancreatitis. 13 Regardless of the inciting mechanism, at least half of all cases of acute pancreatitis are due to the passage of small stones, usually 5 mm or less in diameter. Gallstones have been recovered in stool from 85 to 95% of patients with acute pancreatitis, as compared with a 10% recovery rate among patients who have symptomatic cholelithiasis without pancreatitis. 7 Furthermore, surgical series in the 1980s showed a high prevalence of bile-duct stones and impacted ampul lary stones (63 to 78%) in patients who underwent surgery within 48 hours after admission to the hospital. 8, 14, 15 It has been proposed that early performance of ERCP with biliary sphincterotomy and removal of the obstructing stone ( Fig. 1B and 1C ) might ameliorate the course of pancreatitis. 16 Indeed, it is now clear that some patients do require biliary drainage and may not survive without it. However, clinical trials have not consistently shown a benefit of this intervention. The challenge to endoscopists, therefore, is to determine which subgroup of patients will benefit from early ERCP and sphincterotomy.
CLINIC A L E V IDENCE
The role and timing of ERCP in patients with acute biliary pancreatitis has long been controversial. Numerous clinical trials [17] [18] [19] [20] [21] [22] [23] [24] (Table S3 in the Supplementary Appendix) that have addressed this issue typically have evaluated the role of early ERCP with or without endoscopic sphincterotomy, as compared with conservative medical management with or without the selective use of ERCP. The timing of ERCP, inclusion criteria, methods of diagnosing biliary pancreatitis, and assessment of severity differ among studies. Perhaps as a result of these factors, results are conflicting, with some studies suggesting a benefit for selected patients undergoing ERCP and others showing no benefit and perhaps a worse outcome, regardless of the severity of disease (Table S4 in the Supplementary Appendix) .
These clinical trials have been reviewed in six meta-analyses and systematic reviews [25] [26] [27] [28] [29] [30] (Tables S5 and S6 in the Supplementary Appendix). The reviews differ with respect to the studies included, largely because of differences in study design and inclusion and exclusion criteria. The consensus is that in the absence of cholangitis and biliary obstruction, performance of early ERCP (within 24 to 72 hours after admission to the hospital) does not lead to a reduction in mortality or in local or systemic complications. Furthermore, the results are not dependent on the predicted severity of pancreatitis. Data provide support for the performance of ERCP in patients with biliary obstruction or cholangitis.
CLINIC A L USE
Most patients with biliary pancreatitis, regardless of the predicted severity, do not benefit from ERCP, with or without sphincterotomy. For initial treatment, we proceed with ERCP within 24 to 48 hours after presentation in patients with acute disease and symptoms or signs of coexisting cholangitis (e.g., fever, jaundice, and sepsis) or persistent biliary obstruction (a conjugated bilirubin level >5 mg per deciliter [86 μmol per liter]). Intervention with ERCP is also considered in patients who have clinical deterioration (e.g., worsening pain, leukocytosis, and a change in vital signs) and increasing liver-enzyme levels. Finally, if radiologic imaging such as abdominal ultrasonography or computed tomography shows a stone in the common bile duct, ERCP should be performed. An unstable medical condition that 153 precludes safe moderate sedation is an absolute contraindication to ERCP; relative contraindications have typically included altered postsurgical anatomical features that prevent endoscopic access to the major papilla and clinically significant coagulopathy (Table 1) . When the decision is made to proceed with ERCP, several clinical issues need to be addressed. For patients with cholangitis or biliary obstruction in whom absorption of vitamin K may be impaired, the prothrombin time, international normalized ratio (INR), or both should be checked and corrected as necessary. An INR below 1.5 is preferred, as well as a platelet count greater than 75,000 per cubic millimeter, particularly when performance of a sphincterotomy is anticipated. Intravenous fluid resuscitation at a rate of more than 250 ml per hour for at least the initial 24 hours after admission should be considered, since avoidance of intravascular depletion appears to improve the outcome in patients with acute pancreatitis. 31 The patient should receive nothing by mouth; if enteral feeding has been used, it should be discontinued well in advance of the procedure (i.e., 6 to 8 hours beforehand). Patients with biliary obstruction require antibiotic prophylaxis before ERCP. The use of a quinolone or cephalosporin is favored, since gram-negative bacilli are most commonly identified when infection complicates this procedure.
Since fluoroscopy is required to visualize the ductal structures during ERCP, the procedure can be performed in the radiology department or in the endoscopy suite if it has a separate fluoroscopy unit available. The procedure is performed with the patient in the prone position, although the left lateral or even supine position may be necessary in some circumstances (e.g., in patients who are morbidly obese and in those with large-volume ascites or an abdominal wound or drains). Personnel in the procedure room include the endoscopist, an anesthesiologist, a radiology technician, and a nurse who assists with the technical aspects of the procedure.
ERCP is performed with the use of a sideviewing duodenoscope (see the video, available at NEJM.org.) An instrument channel allows for passage of the catheter, sphincterotome, and other accessories through the duodenoscope, and an elevator allows for deflection of the instruments. The duodenoscope is passed through the patient's mouth to the descending duodenum. Biliary cannulation is then attempted, with care taken to avoid or minimize entry into the pancreas. Cannulation with a wire-guided sphincterotome is typically attempted (Fig. 1B ) in anticipation of a sphincterotomy.
Once successful cannulation is achieved, contrast material is injected into the biliary tree, and digital fluoroscopic images are captured. If cholangitis is suspected, bile is aspirated before injection of contrast material in order to decompress the biliary tree and minimize the risk of dissemination of infection. Bile may be obtained for culture to aid in the choice of antibiotic coverage.
If a stone is identified, the biliary orifice is opened with the use of a sphincterotome (Fig. 1B) . Electrocautery with a wire from the sphincterotome is used to cut the biliary sphincter segment. Tension is applied to the wire to create a curve in the tip of the catheter; this exposes the wire and allows for adjustment. The nurse assistant controls the amount of tension applied to the wire by varying the traction on the handle of the sphincterotome, while the endoscopist controls the cautery by using a foot pedal attached to an electrical generator.
Small-to-medium-size stones (≤1 cm in diameter) can usually be removed easily with a retrieval balloon, which is used to sweep the bile duct, removing the stone (or stones) below (Fig. 1C) . Retrieval of larger stones may require the use of a basket-tipped catheter, which allows for the greater force needed to pull the stone through the biliary orifice. Occasionally, the tip of an impacted stone can be seen protruding from the biliary orifice of a bulging major papilla. In these cases, the experienced endoscopist may consider the use of a needle-knife sphincterotome, which deploys a short, bare wire that is used to cut directly over the impacted stone, facilitating its removal. Advanced techniques such as stone fragmentation (lithotripsy) are sometimes necessary to remove large stones, although further balloon dilation of the biliary orifice after sphincterotomy may suffice. Placement of a bile-duct stent during ERCP may be useful in several circumstances. If complete stone removal is not accomplished during a single procedure, if there are additional stones in the gallbladder with a patent cystic duct (unless cholecystectomy is planned within the next several days), or if active cholangitis is present, stent placement may be considered to facilitate bile drainage. A second ERCP procedure will then be necessary for stent removal and clearance of any remaining stones.
The ERCP procedure time ranges from 20 minutes to more than 1 hour, depending on the ease of cannulation, the number and size of the stones, the skill level of the endoscopist, and other factors. After completion of the procedure, the patient is monitored in the recovery area, initially to assess cardiopulmonary stability and for signs of procedural complications. When discharge criteria are met (usually within 1 to 2 hours after the procedure), the patient is returned to the hospital ward for ongoing care.
If a ductal stone is not visualized during ERCP and there is strong clinical suspicion of a stone, an empirical biliary sphincterotomy is performed. Microlithiasis can result in an attack of pancreatitis that is as severe as that associated with a larger stone, and small stones may not be seen on fluoroscopy. Furthermore, some patients with acute biliary pancreatitis may not be considered candidates for cholecystectomy because of coexisting medical illnesses. A biliary sphincterotomy will prevent recurrent episodes of biliary pancreatitis without the risks associated with operative intervention in patients who are unable to undergo surgery because of advanced age or disease, 32-34 and in pregnant patients. 35, 36 Facility and hospital costs for ERCP vary according to the institution. In 2012, the Medicare physician reimbursement for an ERCP with sphincterotomy and stone removal was $568. Placement of a stent increased this amount to $651 and necessitated a second procedure for stent removal (and possibly further stone removal). Medicare paid approximately $350 for anesthesiology costs, $600 for recovery-room costs, and $250 for pharmacy costs.
A DV ER SE EFFEC T S
Pancreatitis is the most common complication after ERCP, with frequency estimates in the range of 2 to 8% among low-risk patients, such as those with uncomplicated choledocholithiasis. 37 Concern about exacerbating pancreatitis in patients with acute biliary pancreatitis delayed the introduction of ERCP as a therapeutic procedure until the 1980s. The trial by Neoptolemos et al. 17 was one of the first to show that ERCP could be performed safely by an expert endoscopist in patients with acute biliary pancreatitis. However, none of the randomized trials 17-24 specifically assessed post-ERCP pancreatitis as a complication, probably because of the difficulty in confirming this diagnosis in patients with established acute biliary pancreatitis.
Other complications of ERCP include bleeding (typically after sphincterotomy), ductal or intestinal perforation, infection, and cardiopulmonary events. When sphincterotomy is not performed, bleeding and periampullary perforations should not occur. However, perforations of the pancreatic duct, the bile duct, or both with wire as well as intestinal perforations due to trauma from the duodenoscope or another instrument (particularly in patients with anatomical alterations after surgery) can occur without a sphincterotomy. Post-ERCP bleeding has been reported in five randomized trials, 17,18,20,22,24 with no significant difference in event rates between the patients assigned to early routine ERCP and those assigned to a conservative treatment strategy (2.6% and 1.4%, respectively; P = 0.40). Post procedure perforation was assessed in two trials, 17,20 with no cases identified.
The trial by Fölsch and colleagues 20 showed an increased incidence of respiratory failure in the ERCP group as compared with the conservativetreatment group (15 of 126 patients [11.9%] 155 confidence interval, 1.63 to 22.9; P = 0.03). Although hypoxemia is not uncommon in patients with pancreatitis, early ERCP did not lead to this complication in the other randomized trials. The reason for the increase in the incidence of respiratory failure in the trial by Fölsch and colleagues remains unclear.
A r e a s of Uncerta int y Early meta-analyses 26-28 suggested that patients with severe biliary pancreatitis benefited from early intervention with ERCP, with or without sphincterotomy. However, subsequent reviews 25,29,30 have not confirmed this benefit in patients who do not have coexisting cholangitis. In patients who have biliary pancreatitis without jaundice, both endoscopic ultrasonography 38, 39 and magnetic resonance cholangiopancreatography [40] [41] [42] are highly accurate in predicting persistent choledocholithiasis, and these tests allow for more appropriate use of ERCP. Indeed, an increasingly favored approach is to perform endoscopic ultrasonography followed by ERCP (while the patient is under the same sedation) only if bile-duct stones are detected. Further studies are needed to determine whether these imaging techniques may obviate the need for intraoperative cholangiography during a subsequent cholecystectomy.
The question of whether all patients with gallbladder stones and biliary pancreatitis should undergo elective cholecystectomy after a biliary sphincterotomy remains controversial. In a randomized trial addressing this question, 120 patients who had undergone ERCP with sphincterotomy and stone extraction were assigned to either laparoscopic cholecystectomy within 6 weeks after the initial procedure or a conservative waitand-see approach. 43 The wait-and-see approach was associated with more biliary-related events, the need for repeat ERCP in some cases, more postoperative complications, and longer hospital stays. We recommend laparoscopic cholecystectomy in patients who are able to undergo surgery after clearance of the bile duct. If ERCP and sphincterotomy are not performed during the initial episode of pancreatitis, surgery should be performed once the acute symptoms have resolved. An intraoperative cholangiogram should be obtained during cholecystectomy, particularly if a preoperative sphincterotomy has not been performed.
In a patient who presents with acute biliary pancreatitis after cholecystectomy, a decision needs to be made regarding whether to perform ERCP. If the patient continues to have abdominal pain and persistently elevated levels of liver enzymes, despite apparent resolution of the pancreatitis, proceeding directly to ERCP is reasonable. If the patient has recovered from the episode of pancreatitis with substantial improvement in (or normalization of) liver-enzyme levels, we perform an evaluation with either magnetic resonance cholangiopancreatography or endoscopic ultrasonography and proceed to ERCP only if choledocholithiasis is identified.
Guidelines
Guidelines from the United Kingdom, published in 2005, support early ERCP (within 72 hours after admission to the hospital) in all patients with predicted or actual severe biliary pancreatitis. 44 However, these recommendations were based on the findings of earlier randomized trials 17-20 as well as reviews by Sharma and Howden 26 and Ayub et al. 27 As noted above, subsequent studies have shown a benefit only in patients with coexisting cholangitis. In 2007, the American Gastroenterological Association published a position statement concluding that the role of routine ERCP in severe biliary pancreatitis remains controversial. 45 Urgent ERCP (within 24 hours after admission) was recommended, however, in patients with cholangitis, and early ERCP (within 72 hours after admission) was recommended if suspicion of persistent bile-duct stones remained high. Recent guidelines published by the American College of Gastroenterology suggest that urgent ERCP (within 24 hours after admission) is indicated in patients with biliary pancreatitis who have concurrent acute cholangitis, but it is not needed in most patients who do not have evidence of ongoing biliary obstruction. 46 
R ecommendations
The patient described in the vignette is a 74-yearold man presenting with acute pancreatitis. The combination of a serum alanine aminotransferase level of 295 U per liter (7 times as high as the normal level) and cholelithiasis identified on abdominal ultrasonography is highly suggestive of a biliary cause. The clinical picture presented is not suggestive of coexisting ascending cholangitis or biliary obstruction (i.e., the serum bilirubin level is normal and the bile duct is normal in diame-ter). This patient should be treated conservatively with aggressive intravenous fluid resuscitation, intravenous analgesics, and antiemetic agents. In this case, we would not routinely proceed with early ERCP (within 72 hours after admission). However, ERCP would be considered if the patient's clinical condition deteriorated, particularly if he had increasing levels of serum liver enzymes, and a biliary sphincterotomy would be performed if a stone in the common bile duct was identified. To reduce the risk of future biliary events, we would recommend cholecystectomy during this same hospital stay if the patient was not at high surgical risk once his pancreatitis resolved. 
